손주혁 / SOHN, Joo-Hyuk
부교수

Department / Institute / Center :
Internal Medicine (medical oncology)
Yonsei Cancer Center, Severance Breast Cancer Clinic

Contact Information

Phone +82-2-2228-8135 Email oncosohn@yuhs.ac Website

Educational Background

Undergraduate Education M.D., Yonsei University College of Medicine, 1993
Final Degree (University, Major) Ph.D., Graduate School, Yonsei University, 2008
Overseas Training (Institute, Supervisor)

Professional Societies and current positions

American Society of Clinical Oncology
American Association of Cancer Research
대한암학회
한국임상암학회
항암요법연구회

Research Area(s)

Translational research, Clinical research
Research Field I am a breast cancer medical oncologist. Therefore, I am mainly interested in clinical trial with new drug (new drug development). Besides clinics, I am performing translational research in the area of circulating tumor cell and cancer stem cell in patients with breast cancer.
Diseases Mostly, breast cancer but gynecologic malignancies such as ovarian and cervical cancers are included.
Possible Collaboration Currently, I am collaborating with experts in microfluidics for the circulating tumor cell research. In terms of new drug development and translational research in breast cancer, it is widely open to all biologists.

Research Methods

Clinical trial
Real-time RT-PCR
Microfluidics system based separation of circulating tumor cell
Immunocytochemical or immunohistochemical stainning FACS

Lab.

연구실사이트 바로가기
Location of Office Div. of Medical Oncology, Yonsei Cancer Center, 1st Floor
Location of Lab. Yonsei Cancer Research Institute, Yonsei Cancer Center, 4th Floor
Contact person Name: 한현주 / Tel: 2228-8045 , / E-mail: mghjhan@yuhs.ac

Major Published Articles and Books

A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer. Joohyuk Sohn, Hyejin Choi, Jun Chang, Sekyu Kim, Changul Lee, Kyungyoung Chung, Daejun Kim, Byungchul Cho, Sangjun Shin, Yongwha Moon, Joohang Kim, Lung Cancer 2006, 54(3); 365-370

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer. Joo Hyuk Sohn,, Yong Wha Moon, Chang Geol Lee, Gwi Eon Kim, Kyung Young Chung, Joon Chang, Se Kyu Kim, Young Sam Kim, Byoung Wook Choi, Hye Jin Choi , Joo-Hang Kim. Cancer 2007: 109(9) ; 1845-1850

Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma. Sohn JH, Choi HJ, Lee JT, Lee JD, Kim JH, Moon YM, Park K, Park KB, Kim E, Yoo NC. Oncology, 2009;76(1):1-9.

Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance. Yong Wha Moon, Joo Hyuk Sohn,Hye Jin Choi, Hyun Chang, Byeong-Woo Park, Seung Il Kim, Seho Park, Ja Seung Koo, Yong Tai Kim, Jae Kyung Roh, hyun Cheol Chung and Joo-Hang Kim . Cancer Chemother pharmacol. 2009 Dec 15. Epub .

Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin.
Kim PH, Sohn JH, Choi JW, Jung Y, Kim SW, Haam S, Yun CO.